Related Experiment Videos
Human oligodendrocytes in dissociated cell culture
F Rihs1, J Kesselring, C Meier
1Neurologische Universitätsklinik, Inselspital, Bern, Switzerland.
Acta Neuropathologica
|January 1, 1989
Summary
Researchers successfully cultured human oligodendrocytes from fetal spinal cords for 14 weeks. This advance allows for extended study of these vital cells in vitro, aiding research into demyelinating diseases.
Area of Science:
- Neuroscience
- Cell Biology
Background:
- Oligodendrocytes are crucial glial cells in the central nervous system responsible for myelin production.
- Demyelinating diseases, such as multiple sclerosis, involve damage to myelin, highlighting the need for oligodendrocyte research.
- Maintaining human oligodendrocytes in culture presents challenges for extended study.
Purpose of the Study:
- To establish a reliable method for culturing human oligodendrocytes from fetal spinal cords.
- To investigate the stability and characteristics of these cultures over an extended period.
- To facilitate research into the role of oligodendrocytes in demyelinating diseases.
Main Methods:
- Dissociated cell cultures were prepared from human fetal spinal cords (10-20 weeks gestation).
- Cultures were maintained for up to 98 days.
- Oligodendrocytes were identified using specific immunocytochemical markers (myelin-associated glycoprotein, myelin basic protein) and electron microscopy.
- Astrocytes were identified using glial fibrillary acidic protein antibodies.
Main Results:
- Human oligodendrocytes were successfully maintained in culture for up to 14 weeks (98 days).
- Immunocytochemistry and electron microscopy confirmed the identity and integrity of cultured oligodendrocytes.
- Stable culture conditions were achieved, allowing for prolonged observation.
Conclusions:
- A modified cell culture method enables the long-term maintenance of human oligodendrocytes.
- These stable in vitro cultures provide a valuable model for studying oligodendrocyte biology.
- This research supports further investigation into oligodendrocytes as targets for treating demyelinating conditions.